Information Provided By:
Fly News Breaks for March 4, 2020
Mar 4, 2020 | 08:05 EDT
BMO Capital analyst Joel Jackson raised the firm's price target on SQM to $30 from $25 and keeps a Market Perform rating on the shares. The analyst notes that while the company's Q4 earnings exceeded his expectations, he believes that 2020 consensus estimates remain too high given that the management expects similar gross profits as in 2019. While iodone continues to trend up, Jackson remains neutral on SQM given the stock's 13-times enterprise value to expected 2020 EBITDA multiple.
News For SQM From the Last 2 Days
There are no results for your query SQM